Enovis Return on Investment 2012-2026 | ENOV
Current and historical return on investment (ROI) values for Enovis (ENOV) over the last 10 years.
| Enovis ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2026-03-31 | $-1.07B | $3.21B | -33.33% |
| 2025-12-31 | $-1.12B | $3.52B | -31.98% |
| 2025-09-30 | $-1.29B | $3.80B | -33.92% |
| 2025-06-30 | $-0.76B | $4.12B | -18.48% |
| 2025-03-31 | $-0.79B | $4.29B | -18.39% |
| 2024-12-31 | $-0.78B | $4.45B | -17.46% |
| 2024-09-30 | $-0.12B | $4.45B | -2.63% |
| 2024-06-30 | $-0.11B | $4.24B | -2.47% |
| 2024-03-31 | $-0.08B | $4.05B | -1.85% |
| 2023-12-31 | $-0.07B | $3.83B | -1.70% |
| 2023-09-30 | $-0.09B | $3.73B | -2.33% |
| 2023-06-30 | $-0.09B | $2.77B | -3.07% |
| 2023-03-31 | $-0.07B | $1.81B | -3.60% |
| 2022-12-31 | $-0.07B | $2.45B | -2.90% |
| 2022-09-30 | $-0.14B | $3.26B | -4.33% |
| 2022-06-30 | $-0.14B | $4.82B | -2.88% |
| 2022-03-31 | $-0.16B | $6.30B | -2.46% |
| 2021-12-31 | $-0.06B | $6.17B | -1.02% |
| 2021-09-30 | $-0.14B | $5.93B | -2.28% |
| 2021-06-30 | $-0.06B | $5.79B | -0.99% |
| 2021-03-31 | $-0.05B | $5.71B | -0.91% |
| 2020-12-31 | $-0.07B | $5.73B | -1.15% |
| 2020-09-30 | $0.20B | $5.72B | 3.42% |
| 2020-06-30 | $0.20B | $6.09B | 3.31% |
| 2020-03-31 | $0.25B | $6.52B | 3.82% |
| 2019-12-31 | $0.20B | $7.01B | 2.91% |
| 2019-09-30 | $0.12B | $6.73B | 1.80% |
| 2019-06-30 | $0.09B | $6.10B | 1.44% |
| 2019-03-31 | $0.09B | $5.42B | 1.68% |
| 2018-12-31 | $0.15B | $4.71B | 3.20% |
| 2018-09-30 | $0.07B | $4.74B | 1.52% |
| 2018-06-30 | $0.11B | $4.80B | 2.33% |
| 2018-03-31 | $0.14B | $4.82B | 2.84% |
| 2017-12-31 | $0.14B | $4.70B | 2.88% |
| 2017-09-30 | $0.26B | $4.60B | 5.70% |
| 2017-06-30 | $0.25B | $4.52B | 5.44% |
| 2017-03-31 | $0.25B | $4.49B | 5.55% |
| 2016-12-31 | $0.24B | $4.54B | 5.22% |
| 2016-09-30 | $0.23B | $4.61B | 4.90% |
| 2016-06-30 | $0.21B | $4.69B | 4.55% |
| 2016-03-31 | $0.24B | $4.75B | 4.99% |
| 2015-12-31 | $0.27B | $4.75B | 5.60% |
| 2015-09-30 | $0.33B | $4.80B | 6.81% |
| 2015-06-30 | $0.40B | $4.88B | 8.20% |
| 2015-03-31 | $0.40B | $5.04B | 7.92% |
| 2014-12-31 | $0.41B | $5.00B | 8.20% |
| 2014-09-30 | $0.42B | $4.83B | 8.76% |
| 2014-06-30 | $0.41B | $4.53B | 8.98% |
| 2014-03-31 | $0.42B | $4.12B | 10.27% |
| 2013-12-31 | $0.41B | $3.87B | 10.51% |
| 2013-09-30 | $0.34B | $3.78B | 8.96% |
| 2013-06-30 | $0.29B | $3.75B | 7.67% |
| 2013-03-31 | $0.24B | $3.74B | 6.31% |
| 2012-12-31 | $0.14B | $3.84B | 3.64% |
| 2012-09-30 | $0.08B | $2.95B | 2.71% |
| 2012-06-30 | $0.03B | $2.07B | 1.59% |
| 2012-03-31 | $-0.01B | $1.21B | -0.83% |
| 2011-12-31 | $0.03B | $0.31B | 8.08% |
| 2011-09-30 | $0.05B | $0.31B | 17.15% |
| 2011-06-30 | $0.06B | $0.31B | 18.58% |
| 2011-03-31 | $0.05B | $0.29B | 15.46% |
| 2010-12-31 | $0.04B | $0.28B | 12.44% |
| 2010-09-30 | $0.03B | $0.28B | 8.81% |
| 2010-06-30 | $0.03B | $0.28B | 9.32% |
| 2010-03-31 | $0.03B | $0.28B | 10.31% |
| 2009-12-31 | $0.04B | $0.28B | 14.40% |
| 2009-09-30 | $0.05B | $0.27B | 19.79% |
| 2009-06-30 | $0.06B | $0.28B | 22.86% |
| 2009-03-31 | $0.02B | $0.29B | 5.10% |
| 2008-12-31 | $0.02B | $0.30B | 6.07% |
| 2008-09-30 | $0.05B | $0.30B | 15.88% |
| 2008-06-30 | $0.07B | $0.21B | 33.29% |
| 2008-03-31 | $0.12B | $0.13B | 94.30% |
| 2007-12-31 | $0.12B | $0.06B | 193.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.405B | $2.248B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |